Biostate AI expands RNA-based precision medicine with new partnerships across China, India and the US
Biostate AI has launched new collaborations in the US, China, and India to expand access to its RNA sequencing-based precision medicine platform, following a $12 million Series A round. The US-based biotech has formed a joint venture in China and multi-year...
Biostate AI unlocks molecular doors to global health with alliances from Boston to Bengaluru
The biotechnology startup has secured strategic research partnerships in the U.S. and India, and a joint venture in China, dramatically expanding the global dataset for their RNA sequencing-based precision medicine solutions.
Biostate AI Unlocks Molecular Doors to Global Health with Alliances from Boston to Bengaluru
Biostate AI uses RNA sequencing, a snapshot of gene activity, to build AI models that accurately guide drug development, therapy selection, and personalized health predictions. The company has solidified its leadership in the development of domestic and global precision medicine solutions with...
Biostate AI Raises $12M to Build RNA-Based Foundation Model for Molecular Diagnostics
Biostate AI has raised $12 million in Series A funding to scale its RNA sequencing platform and train a general-purpose AI model capable of predicting disease and therapy response. The round was led by Accel with participation from Gaingels, Mana Ventures,...
Biostate AI Secures $12M in Series A Funding Led by Accel
Biotech startup Biostate AI has raised $12 million in a Series A funding round led by Accel. Gaingels, Mana Ventures, and InfoEdge Ventures joined this funding round with existing investors Matter Venture Partners, Vision Plus Capital, and Catapult Ventures.
Biostate AI Secures $12M to Optimize RNA Sequencing, Precision Medicine
Biostate AI, an innovator at the intersection of artificial intelligence and RNA sequencing raises $12M in Series A funding spearheaded by Accel, with participation from Gaingels, Mana Ventures, InfoEdge Ventures, and existing investors Matter Venture Partners, Vision Plus Capital, and Catapult...